Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 2:12 AM
Ignite Modification Date: 2025-12-26 @ 12:40 AM
NCT ID: NCT01575860
Description: None
Frequency Threshold: 0
Time Frame: Adverse event data were collected from each subject's first dose of lenalidomide to twenty-eight days following each subject's last dose of lenalidomide, or upon resolution of any treatment-related adverse events, should their duration extend beyond the 28-day reporting period up to 28 days +/- 7 days after participant study discontinuation.
Study: NCT01575860
Study Brief: Maintenance Lenalidomide in Lymphoma
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Maintenance Lenalidomide in Lymphoma Total of twenty-four (24) 28-day cycles of lenalidomide, 10mg, oral tablets, daily Lenalidomide: Lenalidomide, 10mg, oral tablets, daily 2 None 0 6 3 6 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
White blood cell decreased SYSTEMATIC_ASSESSMENT Investigations CTCAE Version 4.0 View
Neutrophil count decreased SYSTEMATIC_ASSESSMENT Investigations CTCAE Version 4.0 View
Fatigue (Grade 1) SYSTEMATIC_ASSESSMENT General disorders CTCAE Version 4.0 View
Fatigue (Grade 2) SYSTEMATIC_ASSESSMENT General disorders CTCAE Version 4.0 View
Cough (Grade 2) SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders CTCAE Version 4.0 View
Diarrhea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE Version 4.0 View
Lung Infection SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders CTCAE Version 4.0 View
Sinusitis SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders CTCAE Version 4.0 View
Hypogammaglobunemia SYSTEMATIC_ASSESSMENT Immune system disorders CTCAE Version 4.0 View